Package 50742-397-30

Brand: buprenorphine and naloxone

Generic: buprenorphine and naloxone
NDC Package

Package Facts

Identity

Package NDC 50742-397-30
Digits Only 5074239730
Product NDC 50742-397
Description

30 POUCH in 1 CARTON (50742-397-30) / 1 FILM in 1 POUCH (50742-397-01)

Marketing

Marketing Status
Marketed Since 2024-08-08
Brand buprenorphine and naloxone
Generic buprenorphine and naloxone
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["BUCCAL", "SUBLINGUAL"], "spl_id": "3f655839-d97b-89d9-e063-6394a90a515a", "openfda": {"unii": ["56W8MW3EN1", "F850569PQR"], "rxcui": ["1010600", "1010604", "1307056", "1307061"], "spl_set_id": ["4951ec29-609b-4836-b0e4-0d9c1d6ae6fe"], "manufacturer_name": ["INGENUS PHARMACEUTICALS, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (50742-397-30)  / 1 FILM in 1 POUCH (50742-397-01)", "package_ndc": "50742-397-30", "marketing_start_date": "20240808"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "50742-397_3f655839-d97b-89d9-e063-6394a90a515a", "dosage_form": "FILM", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "50742-397", "dea_schedule": "CIII", "generic_name": "buprenorphine and naloxone", "labeler_name": "INGENUS PHARMACEUTICALS, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE", "strength": ".5 mg/1"}], "application_number": "ANDA212756", "marketing_category": "ANDA", "marketing_start_date": "20230829", "listing_expiration_date": "20261231"}